Speech-Language Pathologists in Ellsworth, ME Accepting Medicare

16 Speech-Language Pathologists found. Showing 1 - 16

Mrs. Rhonda L Haskell, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 14 Toothaker Ln, Suite # 4, Ellsworth, ME 04605 Phone: 207-460-1354

Diane M Havey, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 248 State St Ste 3a, Ellsworth, ME 04605 Phone: 207-667-4413    Fax: 207-667-6493

Amy Kennedy, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 248 State St Ste 3a, Ellsworth, ME 04605 Phone: 207-667-4413    Fax: 207-667-6493

Jalisa Patten, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 50 Union St, Ellsworth, ME 04605 Phone: 207-664-5311

Margaret Pierce, CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 16 Kids Peace Way, Ellsworth, ME 04605 Phone: 207-667-0909

Mary M Callow, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 190 Bangor Rd, Suite A, Ellsworth, ME 04605 Phone: 207-667-7108    Fax: 207-664-0461

Jessica Anne Pelletier, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 98 Main St Ste A, Ellsworth, ME 04605 Phone: 207-664-6175

Tabitha E Varney, SP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 16 Kids Peace Way, Ellsworth, ME 04605 Phone: 800-992-9543    Fax: 207-667-6348

Diana Haskell, CCC-/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 248 State St Ste 3a, Ellsworth, ME 04605 Phone: 207-667-4413    Fax: 207-667-6493

Seaport Village Skilled Nursing Center Llc Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 19 General Moore Way, Ellsworth, ME 04605 Phone: 207-667-9336

Ms. Cindy Lou Cowing, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 15 Brae Dr, Ellsworth, ME 04605 Phone: 207-667-0615

Suzanne Bishop Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 16 Kids Peace Way, Ellsworth, ME 04605 Phone: 207-667-0909

Kathleen Mcglinchey, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 248 State St Ste 3a, Ellsworth, ME 04605 Phone: 207-667-4413    Fax: 207-667-6493

Blake Stevens Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 19 General Moore Way, Ellsworth, ME 04605 Phone: 207-667-9336    Fax: 207-664-0379

Kelsea Paige Bouchard Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 19 General Moore Way, Ellsworth, ME 04605 Phone: 207-667-9336

Martha Sullivan Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 16 Kids Peace Way, Ellsworth, ME 04605 Phone: 207-667-0909    Fax: 207-667-6348

News Archive

Study using Cubresa SPECT scanner finds potential non-invasive diagnosis for Alzheimer's

Cubresa's SPECT scanner was used to determine if a novel molecular label, TRV6001, in development for in vivo imaging of the BChE enzyme present in the brains of Alzheimer's Disease patients follows the known distribution of the enzyme in animal models of the disease.

FDA approves Watson Pharmaceuticals' generic version of VALTREX tablets

Watson Pharmaceuticals, Inc., today announced that its subsidiary, Watson Laboratories, Inc., has received approval from the United States Food and Drug Administration on its Abbreviated New Drug Application for Valacyclovir Hydrochloride tablets, USP, in the 500 and 1000 mg strengths, the generic equivalent to GlaxoSmithKline, LLC's VALTREX tablets.

FDA warns 10 companies for selling unlawful dietary supplements that claim to treat mental health problems

Today, the U.S. Food and Drug Administration announced warning letters to 10 companies for illegally selling dietary supplements that claim to cure, treat, mitigate, or prevent depression and other mental health disorders, in violation of the Federal Food, Drug, and Cosmetic Act (FD&C Act).

Boehringer Ingelheim Pharmaceuticals receives FDA approval for Mirapex ER in treatment of early PD

Boehringer Ingelheim Pharmaceuticals, Inc., today announced that the U.S. Food and Drug Administration (FDA) has approved Mirapex ER® (pramipexole dihydrochloride) extended-release tablets, a new once-daily treatment option for the signs and symptoms of early idiopathic Parkinson's disease (PD). MIRAPEX ER is not indicated in advanced PD. Parkinson's disease is a chronic, slowly progressive and potentially debilitating neurological condition affecting nearly one million people in the U.S., with one person newly diagnosed every nine minutes.

Read more Medical News

› Verified 7 days ago